Corbus Pharmaceuticals
CRBP
CRBP
99 hedge funds and large institutions have $129M invested in Corbus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
47% less capital invested
Capital invested by funds: $243M → $129M (-$114M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
99
Holding in Top 10
–
Calls
$6.57M
Puts
$776K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$3.06M | |
| 3 | +$2.78M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$2.24M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$1.65M |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$4.33M | |
| 3 | -$4.22M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.96M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.75M |